|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.19 USD | -0.53% |
|
-1.93% | -33.59% |
| 05-21 | Piper Sandler Initiates Sotera Health at Neutral Rating With $13 Price Target | MT |
| 05-21 | Piper Sandler Starts Sotera Health With Neutral Rating, $13 Price Target | MT |
Sotera Health Company reaffirmed earnings guidance for the year 2022. Net revenues in the range of $1.0 billion to $1.03 billion, representing growth of approximately 7% to 11%, compared to the prior year.
| 1st Jan change | Capi. | |
|---|---|---|
| -33.59% | 3.18B | |
| +16.49% | 83.4B | |
| -29.52% | 72.11B | |
| 0.00% | 27.04B | |
| -13.29% | 16.96B | |
| +1.03% | 16.86B | |
| +1.57% | 15.76B | |
| +71.63% | 13.33B | |
| +1.53% | 12.76B | |
| +70.68% | 12.74B |
SOTERA HEALTH COMPANY 
